These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 3402466)
1. Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure. Baumann G; Gutting M; Pfafferott C; Ningel K; Klein G Eur Heart J; 1988 May; 9(5):503-12. PubMed ID: 3402466 [TBL] [Abstract][Full Text] [Related]
2. [Dopexamine: a new dopaminergic agonist]. Perrin G; Papazian L; Martin C Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure. Tan LB; Littler WA; Murray RG Int J Cardiol; 1991 Feb; 30(2):203-8. PubMed ID: 2010243 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy--a comparative study with dobutamine and sodium nitroprusside. Baumann G; Felix S; Sattelberger U; Klein G J Cardiovasc Pharmacol; 1990 Jul; 16(1):93-100. PubMed ID: 1696672 [TBL] [Abstract][Full Text] [Related]
5. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine. Jaski BE; Peters C Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597 [TBL] [Abstract][Full Text] [Related]
6. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy. Carroll JD; Lang RM; Neumann AL; Borow KM; Rajfer SI Circulation; 1986 Oct; 74(4):815-25. PubMed ID: 3757193 [TBL] [Abstract][Full Text] [Related]
7. Changes in regional blood flow distribution induced by infusions of dopexamine hydrochloride or dobutamine in anesthetized dogs. Biro GP; Douglas JR; Keon WJ; Taichman GC Am J Cardiol; 1988 Aug; 62(5):30C-36C. PubMed ID: 3407595 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic comparison of dopexamine and nitroprusside at high and low doses in patients with coronary artery disease and impaired left ventricular function. Ikram H; Foy SG; Low CJ; Redfern SA; Shirlaw TM; Bennett SI; Crozier IG J Cardiovasc Pharmacol; 1995 Nov; 26(5):777-83. PubMed ID: 8637193 [TBL] [Abstract][Full Text] [Related]
9. Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation? Meinertz T; Drexler H; Just H Basic Res Cardiol; 1989; 84 Suppl 1():177-86. PubMed ID: 2573340 [TBL] [Abstract][Full Text] [Related]
10. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs. Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output. Baumann G; Felix SB; Filcek SA Am J Cardiol; 1990 Mar; 65(11):748-54. PubMed ID: 1969223 [TBL] [Abstract][Full Text] [Related]
12. Influence of sodium nitroprusside and dobutamine on the haemodynamic effects produced by each other. Meretoja OA Acta Anaesthesiol Scand; 1980 Jun; 24(3):195-8. PubMed ID: 7445937 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy. Baumann G; Ningel K; Permanetter B J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521 [TBL] [Abstract][Full Text] [Related]
14. Inotropic mechanisms of dopexamine hydrochloride in horses. Muir WW Am J Vet Res; 1992 Aug; 53(8):1343-6. PubMed ID: 1354950 [TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate. Bayliss J; Thomas L; Poole-Wilson P J Cardiovasc Pharmacol; 1987 May; 9(5):551-4. PubMed ID: 2439836 [TBL] [Abstract][Full Text] [Related]
16. The effects of dopexamine on the cardiovascular system of the dog. Brown RA; Farmer JB; Hall JC; Humphries RG; O'Connor SE; Smith GW Br J Pharmacol; 1985 Jul; 85(3):609-19. PubMed ID: 4027482 [TBL] [Abstract][Full Text] [Related]
17. Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride. Lang RM; Borow KM; Neumann A; Carroll JD; Weinert L; Murphy MB; Ghali J; Rajfer SI Am J Cardiol; 1988 Aug; 62(5):46C-52C. PubMed ID: 2841838 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure. Baumann G; Ningel K; Permanetter B J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. MacGregor DA; Butterworth JF; Zaloga CP; Prielipp RC; James R; Royster RL Chest; 1994 Sep; 106(3):835-41. PubMed ID: 7915979 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of dobutamine and dopexamine after cardiopulmonary bypass in pediatric cardiac surgery. Kwapisz MM; Neuhäuser C; Scholz S; Welters ID; Löhr T; Koch T; Valeske K; Akintürk H; Thul J; Müller M Paediatr Anaesth; 2009 Sep; 19(9):862-71. PubMed ID: 19650844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]